Show simple item record

dc.contributor.authorLarson, NB
dc.contributor.authorMcDonnell, S
dc.contributor.authorAlbright, LC
dc.contributor.authorTeerlink, C
dc.contributor.authorStanford, J
dc.contributor.authorOstrander, EA
dc.contributor.authorIsaacs, WB
dc.contributor.authorXu, J
dc.contributor.authorCooney, KA
dc.contributor.authorLange, E
dc.contributor.authorSchleutker, J
dc.contributor.authorCarpten, JD
dc.contributor.authorPowell, I
dc.contributor.authorBailey-Wilson, J
dc.contributor.authorCussenot, O
dc.contributor.authorCancel-Tassin, G
dc.contributor.authorGiles, G
dc.contributor.authorMacInnis, R
dc.contributor.authorMaier, C
dc.contributor.authorWhittemore, AS
dc.contributor.authorHsieh, C-L
dc.contributor.authorWiklund, F
dc.contributor.authorCatalona, WJ
dc.contributor.authorFoulkes, W
dc.contributor.authorMandal, D
dc.contributor.authorEeles, R
dc.contributor.authorKote-Jarai, Z
dc.contributor.authorAckerman, MJ
dc.contributor.authorOlson, TM
dc.contributor.authorKlein, CJ
dc.contributor.authorThibodeau, SN
dc.contributor.authorSchaid, DJ
dc.date.accessioned2017-11-22T10:43:05Z
dc.date.issued2016-09-01
dc.identifier.citationGenetic epidemiology, 2016, 40 (6), pp. 461 - 469
dc.identifier.issn0741-0395
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/919
dc.identifier.eissn1098-2272
dc.identifier.doi10.1002/gepi.21983
dc.description.abstractRare variants (RVs) have been shown to be significant contributors to complex disease risk. By definition, these variants have very low minor allele frequencies and traditional single-marker methods for statistical analysis are underpowered for typical sequencing study sample sizes. Multimarker burden-type approaches attempt to identify aggregation of RVs across case-control status by analyzing relatively small partitions of the genome, such as genes. However, it is generally the case that the aggregative measure would be a mixture of causal and neutral variants, and these omnibus tests do not directly provide any indication of which RVs may be driving a given association. Recently, Bayesian variable selection approaches have been proposed to identify RV associations from a large set of RVs under consideration. Although these approaches have been shown to be powerful at detecting associations at the RV level, there are often computational limitations on the total quantity of RVs under consideration and compromises are necessary for large-scale application. Here, we propose a computationally efficient alternative formulation of this method using a probit regression approach specifically capable of simultaneously analyzing hundreds to thousands of RVs. We evaluate our approach to detect causal variation on simulated data and examine sensitivity and specificity in instances of high RV dimensionality as well as apply it to pathway-level RV analysis results from a prostate cancer (PC) risk case-control sequencing study. Finally, we discuss potential extensions and future directions of this work.
dc.formatPrint-Electronic
dc.format.extent461 - 469
dc.languageeng
dc.language.isoeng
dc.publisherWILEY
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved
dc.subjectHumans
dc.subjectBayes Theorem
dc.subjectCase-Control Studies
dc.subjectSequence Analysis, DNA
dc.subjectModels, Genetic
dc.subjectGenetic Variation
dc.subjectHigh-Throughput Nucleotide Sequencing
dc.titlePost hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing Studies.
dc.typeJournal Article
dcterms.dateAccepted2016-04-27
rioxxterms.versionofrecord10.1002/gepi.21983
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2016-09
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfGenetic epidemiology
pubs.issue6
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics
pubs.publication-statusPublished
pubs.volume40
pubs.embargo.termsNot known
icr.researchteamOncogenetics
dc.contributor.icrauthorEeles, Rosalind
dc.contributor.icrauthorKote-Jarai, Zsofia


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record